| Date Filed | Type | Description |
| 04/23/2019 |
4
| Lewicki John A. (President and CEO) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Unknown transaction of 142,534 shares
@ $0 |
|
| 02/13/2019 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 10/11/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2018 |
4
| Lewicki John A. (President & CEO) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 4,557 shares
@ $2.6777, valued at
$12.2k
|
|
| 03/19/2018 |
4
| Lewicki John A. (President & CEO) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Granted 125,000 options to buy
@ $2.98, valued at
$372.5k
|
|
| 02/23/2018 |
4
| Lewicki John A. (President) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Granted 125,000 options to buy
@ $2.23, valued at
$278.8k
|
|
| 02/06/2018 |
5
| Lewicki John A. (President) has filed a Form 5 on OncoMed Pharmaceuticals Inc |
| 01/08/2018 |
4
| Lewicki John A. (EVP, Research & Development) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Granted 100,000 options to buy
@ $3.98, valued at
$398k
|
|
| 10/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2017 |
4
| Lewicki John A. (EVP, Research & Development) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Granted 22,500 shares
@ $0
Granted 67,500 options to buy
@ $3.73, valued at
$251.8k
|
|
| 04/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/11/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/29/2015 |
4
| Lewicki John A. (EVP & Chief Scientific Officer) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Granted 70,000 options to buy
@ $21.43, valued at
$1.5M
|
|
| 06/17/2015 |
4
| Lewicki John A. (EVP & Chief Scientific Officer) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 8,500 shares
@ $24.9167, valued at
$211.8k
Sold 8,500 shares
@ $25.2156, valued at
$214.3k
Exercised 8,500 options to buy
@ $1.43, valued at
$12.2k
Exercised 5,602 options to buy
@ $1.43, valued at
$8k
Exercised 2,898 options to buy
@ $3.42, valued at
$9.9k
|
|
| 04/03/2015 |
4
| Lewicki John A. (EVP & Chief Scientific Officer) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 8,500 shares
@ $25.1888, valued at
$214.1k
Sold 6,940 shares
@ $25.2904, valued at
$175.5k
Sold 1,560 shares
@ $25.6979, valued at
$40.1k
Exercised 8,500 options to buy
@ $1.43, valued at
$12.2k
Exercised 8,500 options to buy
@ $1.43, valued at
$12.2k
|
|
| 02/04/2015 |
4/A
| Lewicki John A. (EVP & Chief Scientific Officer) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Exercised 4,000 options to buy
@ $1.43, valued at
$5.7k
|
|
| 02/04/2015 |
4
| Lewicki John A. (EVP & Chief Scientific Officer) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 4,000 shares
@ $22.4878, valued at
$90k
Exercised 4,000 options to buy
@ $1.43, valued at
$5.7k
|
|
| 01/05/2015 |
4
| Lewicki John A. (EVP & Chief Scientific Officer) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 3,600 shares
@ $22.0257, valued at
$79.3k
Sold 400 shares
@ $22.7897, valued at
$9.1k
Exercised 4,000 options to buy
@ $1.43, valued at
$5.7k
|
|
| 12/22/2014 |
4
| Lewicki John A. (EVP & Chief Scientific Officer) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Granted 50,000 options to buy
@ $21.18, valued at
$1.1M
|
|
| 12/03/2014 |
4
| Lewicki John A. (EVP & Chief Scientific Officer) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 4,000 shares
@ $21.188, valued at
$84.8k
Exercised 4,000 options to buy
@ $1.43, valued at
$5.7k
|
|
| 11/05/2014 |
4
| Lewicki John A. (EVP & Chief Scientific Officer) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Gifted 602 shares
@ $0
Sold 4,000 shares
@ $20.4546, valued at
$81.8k
Gifted 602 shares
@ $0
Exercised 4,000 options to buy
@ $1.43, valued at
$5.7k
|
|
| 10/03/2014 |
4
| Lewicki John A. (EVP & Chief Scientific Officer) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 5,809 shares
@ $20, valued at
$116.2k
Exercised 5,809 options to buy
@ $1.43, valued at
$8.3k
|
|
| 09/03/2014 |
4
| Lewicki John A. (EVP & Chief Scientific Officer) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 2,191 shares
@ $20.005, valued at
$43.8k
Exercised 2,191 options to buy
@ $1.43, valued at
$3.1k
|
|
| 08/04/2014 |
4
| Lewicki John A. (EVP & Chief Scientific Officer) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 4,000 shares
@ $20.9781, valued at
$83.9k
Exercised 4,000 options to buy
@ $1.43, valued at
$5.7k
|
|
| 07/03/2014 |
4
| Lewicki John A. (EVP & Chief Scientific Officer) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 3,296 shares
@ $23.7508, valued at
$78.3k
Sold 704 shares
@ $24.3626, valued at
$17.2k
Exercised 4,000 options to buy
@ $1.43, valued at
$5.7k
|
|
| 07/03/2014 |
4/A
| Lewicki John A. (EVP & Chief Scientific Officer) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 1,362 shares
@ $24.1908, valued at
$32.9k
Sold 2,638 shares
@ $24.7916, valued at
$65.4k
|
|
| 06/17/2014 |
4
| Lewicki John A. (EVP & Chief Scientific Officer) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 4,000 shares
@ $24.587, valued at
$98.3k
Exercised 4,000 options to buy
@ $1.43, valued at
$5.7k
|
|
| 03/27/2014 |
4
| Lewicki John A. (EVP & Chief Scientific Officer) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Gifted 1,792 shares
@ $0
Gifted 1,792 shares
@ $0
Granted 20,000 shares
@ $0 |
|
| 03/12/2014 |
4
| Lewicki John A. (EVP & Chief Scientific Officer) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Gifted 81,136 shares
@ $0
Gifted 81,136 shares
@ $0 |
|
| 07/23/2013 |
4
| Lewicki John A. (EVP & Chief Scientific Officer) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Converted 3,132 shares
@ $0
Converted 5,159 shares
@ $0
Converted 3,132 options to buy
@ $0
Converted 5,159 options to buy
@ $0 |
|
|